Yilma Larebo*, Dawit Erjino and Tegegn Arficho
Introduction: Individual patient and public health intervention related positive health outcomes are directly related to anti-retroviral treatment care retention. However, one to two thirds of people infected with human immune virus/acquired immune deficiency syndrome do not receive regular care. As a result, the purpose of this study was to determine the status of retention on care and associated factors among adult anti-retroviral treatment recipients.
Methods: From March to April 2015, a cross-sectional study was conducted on 305 patients. The participants were chosen using a systematic random sampling method. The checklist was used to retrieve data from the anti-retroviral treatment registration logbook, patient intake form, and antiretroviral treatment follow up form. A logistic regression analysis was used to identify factors associated with anti-retroviral treatment retention. An odds ratio with a 95% confidence interval was also used to identify factors that were significantly associated with care retention.
Results: Study identified 75.7% of overall retention on anti-retroviral treatment care. Being female sex (AOR=4.04; 95% CI; 2.05, 8.00), higher educational status (AOR=2.75; 95% CI; 1.24, 6.10), human immune virus/ acquire immune deficiency syndrome status disclosure (AOR=9.26; 95% CI; 4.06, 21.12), low addiction in alcohol/tobacco (AOR=2.3;95% CI; 1.02, 5.21) and with history of drug regimen change (AOR=3.58;95% CI;1.59,8.09) was a significant positive relation with retention on anti-retroviral treatment care.
Conclusion: The study discovered a lower level of retention in anti-retroviral treatment care; whereas ongoing counseling on the importance of staying on care; disclosing one's self-human immune virus/ acquired immune deficiency syndrome status to a family member and reducing substance abuse are all recommended.
Published Date: 2023-01-30; Received Date: 2022-05-04
